The landscape of dementia diagnosis has advanced drastically with the arrival of subtle biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent checks that can detect Alzheimer's pathology many years just before signs or symptoms arise. Though these technological innovations represent exceptional progress in comprehension neu